Vetoquinol SA

As of June 30, 2026, Vetoquinol SA carries a market capitalization of 837.64M, placing it among publicly traded companies globally. Its enterprise value stands at 614.86M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Vetoquinol SA's next confirmed earnings release is scheduled for March 25, 2027.

As of June 30, 2026, Vetoquinol SA has 11.81M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Vetoquinol SA maintains a current ratio of 3.35, meaning it holds 3.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 23, 2026, Vetoquinol SA's stock has gained approximately 1.79% over the past 52 weeks. The 50-day moving average sits at 73.86, while the 200-day moving average is 76.20.

As of June 30, 2026, Vetoquinol SA holds 235.20M in cash and equivalents against 12.35M in total debt, resulting in a net debt position of -235.02M. Total book value stands at 608.73M, with working capital of 330.19M providing operational flexibility.